3[4]Schena M,Schalon D,Davis RW,et al.Quantitative monitoring of gene expression patterns with a complemetary DNA microarray [J].Science,1995,270(5235):467-470.
2Schena M, Shalon D. Davis RW, et al . Quantitative monitoring of gene expression patterns with a complementary DNA microarray [J]. Science, 1995,270(20): 467～480.?A
3Zhang JP, Ying K, Xiao ZY, et al. Analysis of gene expression profiles in human HL-60 cell exposed to cantharidin using cDNA microarray [J]. Int J Cancer, 2004, 108(2):212～218.?A
4Rutk JT, Taylor M, Mainprize T, et al . Molecular biology and neurosurgery in the third millennium [J]. Neurosurgery,2000, 46(5): 1034～1051.?A
5Alizadeh AA, Ross DT, Perou CM, et al . Towards a novel classification of human malignancies based on gene expression patterns [J]. J Pathol, 2001, 195(1): 41～52.?A
6Liu Y, Saad RS, Shen SS, et al . Diagnostic value of microtubule-associated protein-2 (MAP-2) for neuroendocrine neoplasms [J]. Adv Anat Pathol. 2003,10(2): 101～106.?A
7Blumcke I, Becker A J, Normann S, et al . Distinct expression pattern of microtubule-associated protein-2 in human oligodendrogliomas and glial precursor cells [J]. J Neuropathol Exp Neurol. 2001, 60(10): 984～993.?A
8Bash-Babula J, Toppmeyer D, Labassi M, et al . A PhaseI/pilot study of sequential doxorubicin/vinorelbine: effects on p53 and microtubule-associated protein 4 [J]. Clin Cancer Res. 2002, 8(5): 1057～1064.?A
9Nishiyama H, Gill JH, Pitt E, et al . Negative regulation of G(1)/S transition by the candidate bladder tumour suppressor gene DBCCR1 [J]. Oncogene. 2001, 20(23): 2956～2964.?A
10Johnson K J, Patel SR, Boekelheide K. Multiple cadherin superfamily members with unique expression profiles are produced in rat testis [J]. Endocrinology. 2000, 141 (2):675～683.?A
2Hiroko O, Paul K. Epidemiology and etiology of gliomas. Acta Neuropathol, 2005,109 : 93-108.
3Yokota T, Kouno J, Adachi K, et al . Identification of histological markers for malignant glioma by gcnome-wide expression analysis: dynein, a-PIX and sorcin. Acta Neuropathol, 2006, 111 : 29-38.
4Rhodes DR, Barrette TR, Rubin MA, et ai. Meta-analysis of microarrays: interstudy validation of genc expression profiles reveals pathway dysregulation in prostate cancer. Cancer Res, 2002,62:4427-4433.
5Jansen M, de Witt Hamer PC, Witmer AN, et al. Current perspectives on antiangiogenesis strategies in the treatment of malignant gliomas. Brain Res Brain Res Rev,2004,45:143-163.
6Hiroko Ohgaki, Paul Kleihues. Epidemiology and etiology of glioma. Acta Neuropathol, 2005,109:93.
7Judith A. James I., Kenneth D,et al. Epidemiology and molecular pathology of glioma. Nature Clinical Practice, 2006,2(9):494.
8Wu C L, Classon M, Dyson N, et al. Expression of dominant negative mutant DP1 blocks cell cycle progression. Mol Cell Biol, 2002,16: 3698.
